JEHSX — Health Sciences Trust
Data updated: 2026-05-29
JEHSX — Health Sciences Trust data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $227.23M AUM · 1.04% expense ratio · 12.8% 1-yr return. From SEC regulatory filings.
JEHSX Fund Overview
JEHSX — Health Sciences Trust is a US mutual fund managed by John Hancock Variable Insurance Trust, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: John Hancock Variable Insurance Trust
- Category: United States Health Care Equity
- Assets under management: $227.23M
- 1-year return: 12.8%
- Ticker: JEHSX
- SEC CIK: 0000756913
- SEC series ID: S000008239
- Share class ID: C000022443
JEHSX Holdings
Top 10 holdings of Health Sciences Trust by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Eli Lilly and Company | 10.20% |
| Thermo Fisher Scientific Inc. | 4.12% |
| Intuitive Surgical Inc. | 3.71% |
| Stryker Corporation | 3.52% |
| Merck and Co. Inc. | 3.48% |
| AstraZeneca PLC | 3.22% |
| UnitedHealth Group Incorporated | 3.13% |
| argenx SE | 2.99% |
| AbbVie Inc. | 2.88% |
| Regeneron Pharmaceuticals Inc. | 2.69% |
JEHSX Portfolio Allocation
Asset-class allocation of Health Sciences Trust by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.2% |
| Cash & Equivalents | 0.7% |
| Fixed Income | 0.1% |
JEHSX Performance
Total returns for JEHSX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -6.2% |
| 1 year | 12.8% |
| 3 years (annualised) | 6.7% |
| 5 years (annualised) | 3.1% |
JEHSX Risk Information
Risk metrics for JEHSX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 17.2%
JEHSX Costs and Fees
JEHSX costs about $104 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.04%
- Gross expense ratio: 1.05%
- Portfolio turnover: 68%
- Brokerage commissions: 3.19 bps of average net assets (SEC N-CEN)
JEHSX Cashflows
Over the 12 months to 2026-03, Health Sciences Trust had net inflows of $3.21M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$2.89M |
| 2026-02 | −$959.99K |
| 2026-01 | $122.73K |
| 2025-12 | −$2.76M |
| 2025-11 | −$2.54M |
| 2025-10 | $30.42M |
JEHSX Debt Constituents
Largest debt holdings of Health Sciences Trust by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Immunocore Holdings plc | 0.11% |
JEHSX Prospectus and SEC Filings
Official Health Sciences Trust filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.